Clinical trial
T-Cell Depleted, Alternative Donor Transplant in Pediatric and Adult Patients With Severe Sickle Cell Disease (SCD) and Other Transfusion-Dependent Anemias
NCT03653338 is registered in ClinicalTrials.gov with Paul Szabolcs as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- T-Cell Depleted, Alternative Donor Transplant in Pediatric and Adult Patients With Severe Sickle Cell Disease (SCD) and Other Transfusion-Dependent Anemias
- Lead sponsor
- Paul Szabolcs
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- August 2, 2018
- Completion date
- August 1, 2028
- Enrollment
- 5 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
beta-thalassemia major, diamond-blackfan anemia, sickle cell anemia